← Back to Investors

Seventure Partners

Seventure Partners is a leading European venture capital firm with a unique focus on the microbiome and life sciences. As a pioneer in microbiome investing, Seventure manages dedicated funds targeting the human, animal, and plant microbiome sectors alongside broader life sciences investments.

Location
Paris, France
Founded
1997
AUM
€1B+
Investment Range
€2M - €20M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c

Investment Thesis

Seventure invests in innovative life sciences companies across Europe and globally, with a distinctive expertise in the microbiome sector. Their Health for Life Capital funds focus on microbiome-based therapeutics, diagnostics, and nutrition, while their broader life sciences funds target therapeutics, medical devices, and digital health.

Team

Partners / Managing Directors

  • Isabelle de Crémoux - CEO & Managing Partner
  • Laurent Bénard - Partner
  • Marc Julien - Partner

Other Key Team Members

  • Nicolas Houba, PhD - Partner
  • Stéphane Grégoire - Partner

Focus Areas

  • Microbiome Therapeutics
  • Microbiome Diagnostics
  • Gut-Brain Axis
  • Nutrition & Microbiome
  • Digital Health
  • Medical Devices
  • Biotechnology

Notable Portfolio Companies

  • Enterome - Microbiome-based cancer immunotherapy
  • MaaT Pharma - Microbiome restoration
  • Eligo Bioscience - Precision microbiome engineering
  • Microbiotica - Microbiome-based therapeutics
  • Symbiomics - Gut microbiome diagnostics

Notable Exits

  • DBV Technologies - IPO (Euronext: DBV, food allergy treatment)
  • Cellectis - IPO (NASDAQ: CLLS, gene editing)
  • Noxxon Pharma - IPO (Euronext)

Sources